NutriStack
Irbesartan and Potassium, a caution.
Irbesartan blocks the angiotensin II type 1 receptor, suppressing aldosterone and reducing renal potassium excretion. Combining it with a potassium supplement increases the risk of hyperkalemia, which can cause muscle weakness, paresthesias, and life-threatening arrhythmias. Patients with chronic kidney disease, diabetes, heart failure, or those on NSAIDs are at the highest risk.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Irbesartan and Potassium
- Pair type
- Caution
- Evidence (highest tier)
- Strong
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Strong evidence
Caution
What is happening. Irbesartan blocks the angiotensin II type 1 receptor, suppressing aldosterone and reducing renal potassium excretion. Combining it with a potassium supplement increases the risk of hyperkalemia, which can cause muscle weakness, paresthesias, and life-threatening arrhythmias. Patients with chronic kidney disease, diabetes, heart failure, or those on NSAIDs are at the highest risk.
Mechanism. Angiotensin II type 1 receptor blockade reduces aldosterone-mediated potassium secretion at the cortical collecting duct. Exogenous potassium then accumulates because renal handling is impaired.
Recommendation. Do not take potassium supplements alongside irbesartan unless your prescriber has documented a deficiency and is monitoring you. If combined use is necessary, check serum potassium within 1-2 weeks of starting and at every dose change. Avoid potassium-containing salt substitutes.
Sources (2)
- Espinel E, Joven J, Gil I, Suñé P, Renedo B, Fort J, Serón D. Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study. BMC Res Notes. 2013;6:306. PMID 23915518
- Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Eur J Prev Cardiol. 2014;21(3):299-309. PMID 24191305
Stack Score
How this pair moves the number.
Effect on the composite score
If both Irbesartan and Potassium are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.